$30 million funding round boosts electro-active composite eyeglass lenses

OCTOBER 27, 2008 -- PixelOptics (Roanoke, VA), a company committed to "transformational innovation" in eyewear lenses for noninvasive vision correction, has closed on a $30 million Series C investment round. The company will use the funds to develop a complete offering of composite eyeglass lenses incorporating its electro-active lens technology.

PixelOptics "is successfully applying its know-how of composite optics, electronics and chemistry to the development of a mainstream product that we expect will benefit millions of people worldwide," said Juliet Bakker, Managing Director of Longitude Capital, which led the financing round. PixelOptics' focus on improving the current standard of vision correction promises a wide range of eye glasses based on "composite lens" and innovative technologies, combined to deliver a vastly improved visual experience.

The first of its products is the recently introduced atLast! Enhanced Multifocal Lenses, designed to compete within the lined multifocal lens market, which sells 45 million pairs of glasses globally each year. The market has not seen any major advances in the last 30 years, according to PixelOptics. The atLast! product incorporates composite lens technology, a combination of advanced lens design technologies and well-known, proven lens materials to create "a completely new category of lens with enhanced optical and cosmetic performance."

Pixel is also developing electro-active dynamic eyewear, which the company says "changes its focus faster than the blink of an eye, and does so without moving parts." This product line will compete within the progressive addition lens market, which accounts for an additional 45 million pairs of lenses being sold each year globally.

PixelOptics was founded in 2005 by Dr. Ron Blum, entrepreneur, inventor, and former general manager of Advanced Technology for the Johnson & Johnson Spectacle Lens Group, to optimize the patented electro-active optical technology and other advances to revolutionize the visual experience of spectacle lens wearers. PixelOptics' management team is comprised of industry veterans from leading optical industry manufacturers. The team includes Dr. Blum, CEO and Chairman; Bill Spies, COO; Bill Kokonaski, CTO; Steve Holt, CFO; Robin Rhodes, VP of Professional Sales; Rod Passerelli, VP of Retail Sales; and Clay Musslewhite, Director of Marketing.

"Longitude Capital takes a stake in companies with exceptional management teams who are developing technologies and products that will help improve and positively transform health care. We believe that PixelOptics is well positioned to become a key player in the growing lens market," noted Longitude's Bakker. In July, Longitude announced a $325 million venture ecapital fund (Longitude Venture Partners, L.P.) dedicated to life science investments.

Additional investors in this funding round include The Carlyle Group, Delphi Ventures, Stark Investments, Life Science Angels, and others. Other existing PixelOptics investors include Panasonic Ventures.

More information:

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

Sales of Coherent lasers for ophthalmology exceed 10,000 units

Coherent has now shipped over 10,000 lasers into ophthalmic applications, including pulsed excimer ultraviolet lasers for LASIK vision correction and continuous-wave (CW) solid-state lasers with gr...

WaveTec Vision secures $16.5M to market cataract surgery system

WaveTec Vision has closed a new round of financing for its recently introduced ORA System, a wavefront aberrometry system for cataract surgery, securing an additional $16.5 million.

Anterior segment module receives FDA clearance

Heidelberg Engineering has gained FDA clearance for its Spectralis anterior segment module, which provides high-resolution images of the cornea, anterior chamber angle, and sclera using the company...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS